Commentary
See article on page 836Iron overload in Montpelier
| The first 150 words of the full text of this article appear below. |
Since the original discovery of the haemochromatosis gene (HFE)
in 1996,1 there have been two genetic mutations that have dominated clinical studies. The C282Y mutation (845 G
A) has
attracted the most attention as the majority of typical
haemochromatosis patients are homozygotes for this mutation. This has
increasingly led to the use of genetic testing for the diagnosis of
haemochromatosis and in many cases has alleviated the need for liver
biopsy. In comparison with most other genetic diseases, it remains a
marvel that a single mutation explains most clinical cases.
Furthermore, in vitro studies have demonstrated that the C282Y mutation
disrupts the normal presentation of the HFE protein on the cell
surface.2 The H63D mutation (187 G
C) was described in
the original description of the HFE gene but
has been relegated to a minor clinical role in comparison with the
C282Y mutation. It is more prevalent than the C282Y mutation with
Relevant Article
- Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
- P Aguilar-Martinez, M Bismuth, M C Picot, C Thelcide, G-P Pageaux, F Blanc, P Blanc, J-F Schved, and D Larrey
Gut 2001 48: 836-842.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
